Hepatitis C symptoms and diagnosis: latest news

Hepatitis C symptoms and diagnosis resources

  • Hepatitis C

    Hepatitis C virus (HCV) is chiefly transmitted by blood-to-blood contact. When the blood of a person with hepatitis C enters the bloodstream of another person,...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • Symptoms

    Patterns of hepatitis C disease progression vary considerably from person to person. Some people never experience symptoms, some rapidly develop symptoms of acute hepatitis and...

    From: HIV treatments directory

    Information level Level 4
  • Diagnosis and monitoring

    A blood test for antibodies to HCV will usually tell whether or not a person has been exposed to the virus. United Kingdom guidelines recommend...

    From: HIV treatments directory

    Information level Level 4
  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, though the two viruses are not related. Recent estimates find that...

    From: Booklets

    Information level Level 2

Hepatitis C symptoms and diagnosis features

Hepatitis C symptoms and diagnosis in your own words

Hepatitis C symptoms and diagnosis news from aidsmap

More news

Hepatitis C symptoms and diagnosis news selected from other sources

  • Cepheid announces European approval of Xpert HCV Viral Load

    Quantitative test for rapid measurement of hepatitis C virus viral load and confirmation of HCV infection delivers on-demand results in less than 2 hours.

    16 April 2015 | Cepheid press release
  • Study: Door-to-door campaign linked hepatitis C patients to care

    Working on the streets in medically underserved Philadelphia neighborhoods, members of the Do One Thing program have been able to identify residents chronically infected with hepatitis C and help them overcome the hurdles that prevent people from being cured, according to a new study in the Journal of General Internal Medicine.

    16 February 2015 | Eurekalert Inf Dis
  • Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C

    In 2 recent studies, statins and aspirin have been associated with lower rates of progression of liver fibrosis in patients with hepatitis C. Strategies for slowing the rate of progression of liver fibrosis are important for these reasons: (1) the high cost of treatment for hepatitis C; and (2) updated guidelines that recommend prioritizing treatment to sicker patients and postponing treatment in other groups.

    11 February 2015 | HCP Live
  • UNITAID publishes comprehensive review of detection and monitoring technologies for hepatitis C

    Diagnosis and screening currently too complex and expensive, but new options emerging.

    20 January 2015 | UNITAID press release
  • NICE plans to support device for diagnosing liver damage without surgery

    NICE is consulting on draft guidance on a device that aims to diagnose and monitor liver damage, without the need for surgery. The provisional recommendations support using the device, Virtual Touch Quantification (VTq), in adults and children with chronic hepatitis B or C who need assessment of liver fibrosis.

    15 January 2015 | NICE
  • Doctors Question Wider Hepatitis C Screening Despite Cures

    Doctors should resist the urge to screen a wider group of patients for hepatitis C, a group of physicians said today in the British Medical Journal, despite the introduction of new drugs that can cure the liver disease. Expanded screening would flag the disease in people who are unlikely to die from it, leading to unnecessary treatment that may itself be harmful, said the group, including Kenneth Lin, an associate professor at Georgetown University School of Medicine.

    14 January 2015 | Bloomberg
  • Hepatitis C ruled out as cause of mental impairment in HIV patients

    “Hepatitis C infection has serious long-term side effects, such as damage to the liver, but our research indicates that it does not affect the brain,” said lead author David Clifford, MD, of Washington University.

    15 December 2014 | Washington University press release
  • Scaling up screening for viral hepatitis in Europe

    A new toolkit on screening for chronic viral hepatitis seeks to raise awareness, improve knowledge and motivate public health professionals in Europe to take action. Knowledge and understanding of what works in screening for chronic hepatitis B/C has now been translated into practical and relevant tools, including videos and animations, to enable others to replicate successful screening programmes among at risk populations in their area.

    15 December 2014 | Medical Xpress
  • Practical steps to eliminating hepatitis C: a consensus for London

    The aim of this document is to reinforce the need for urgent leadership from the Department of Health, PHE and NHS England and concerted action from Local Authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (CCGs) and service providers to improve hepatitis C testing and treatment services in London for people with a history of using drugs – the group most affected by chronic hepatitis C – in order to find and treat significantly more people affected by the disease.

    17 November 2014 | London Joint Working Group on Substance Use and Hepatitis C
  • Half of people with hepatitis C unaware

    Dr Vivian Hope of Public Health England said: "With around half of those people living with hepatitis C still unaware of their infection, we need to do more to increase diagnosis rates. Ultimately, this will help reduce the current high level of infection we’re still seeing among people who inject drugs."

    05 November 2014 | Public Health England press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.